Binimetinib Impurity 19 | CAS 284030-57-5 - Request Quote
Binimetinib Impurity 19
| SZ CAT No: | SZ-B053036 |
| CAS No | 284030-57-5 |
| Mol.F. | C7H4F2N2O4 |
| Mol.Wt. | 218.1 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Binimetinib Impurity 19 is chemically 4-Amino-2,3-difluoro-5-nitrobenzoic acid. Binimetinib Impurity 19 is supplied with detailed characterization data compliant with regulatory guideline. Binimetinib Impurity 19 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Binimetinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 284030-57-5
Purchase 284030-57-5
Order 284030-57-5
Enquire 284030-57-5
price of 284030-57-5
284030-57-5 Supplier
284030-57-5 Manufacturer
284030-57-5 Exporter
buy high quality Binimetinib Impurity 19
Purchase Binimetinib Impurity 19
Binimetinib Impurity 19 suppliers
Binimetinib Impurity 19 manufacturers
Binimetinib Impurity 19 price
Order Binimetinib Impurity 19
Enquire Binimetinib Impurity 19
Binimetinib Impurity 19 cost
Binimetinib Impurity 19 Supplier
Binimetinib Impurity 19 Distributor
Binimetinib Impurity 19 for Method Validation
Binimetinib Reference Standard
Binimetinib Impurity 19 for ANDA Filing
Binimetinib Impurity 19 for Forced Degradation Studies
Binimetinib Impurity 19 Identification Standards
Binimetinib Impurity 19 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.